{"url_path":"/sec/lmed/10-q/2026/item-1","section_key":"item-1","section_title":"Item 1 Condensed Financial Statements.**","topic":"sec","document":{"doc_type":"10-Q","doc_date":"2026-05-20","source_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","accession_number":"0001477932-26-003348","cik":"0001477960","ticker":"LMED","issuer_name":"LataMed AI Corp.","edgar_url":"https://www.sec.gov/Archives/edgar/data/1477960/0001477932-26-003348-index.html","primary_entity_key":"0001477960","primary_entity_name":"LataMed AI Corp."},"word_count":4505,"has_tables":true,"body_markdown":"**Item 1. Condensed Financial Statements.**\n\n \n\n**LataMed AI Corp.**\n\n**(FKA Catalyst Crew Technologies Corp.)**\n\n**CONDENSED BALANCE SHEETS**\n\n**(Unaudited)**\n\n \n\n \n\n** **\n\n**March 31, 2026**\n\n** **\n\n** **\n\n**December 31, 2025**\n\n \n\nASSETS\n\n \n\n \n\n \n\n \n\n \n\n \n\nCurrent assets\n\n \n\n \n\n \n\n \n\n \n\n \n\nCash\n\n \n$-\n \n\n \n$-\n \n\nTotal current assets\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nIntangible assets\n\n \n\n \n7,824,000\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n Total assets\n\n \n\n \n7,824,000\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nLIABILITIES AND STOCKHOLDERS' DEFICIT\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCurrent liabilities\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nAccounts payable and accrued liabilities\n\n \n\n \n260,352\n \n\n \n\n \n235,923\n \n\nNotes payable - related party\n\n \n\n \n88,042\n \n\n \n\n \n88,042\n \n\nNotes payable\n\n \n\n \n300,688\n \n\n \n\n \n272,304\n \n\nConvertible notes payable\n\n \n\n \n34,591\n \n\n \n\n \n34,591\n \n\nTotal current liabilities\n\n \n\n \n683,673\n \n\n \n\n \n630,860\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTotal liabilities\n\n \n\n \n683,673\n \n\n \n\n \n630,860\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nStockholders' deficit\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nPreferred stock, $0.0001 par value, 280,000,000 shares authorized, 0 and 0 and shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nSeries A Preferred stock, $0.0001 par value, 20,000,000 shares authorized, 0 and 0 and shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nSeries B Preferred stock, $0.0001 par value, 20,000,000 shares authorized, 0 and 0 and shares issued and outstanding as of March 31, 2026 and December 31, 2025, respectively\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCommon stock, $0.0001 par value, 700,000,000 shares authorized, 243,632 and 243,632 and shares issued and outstanding as of March 31, 2026 and December 31, 2025\n\n \n\n \n56,136\n \n\n \n\n \n44,298\n \n\nAdditional paid in capital\n\n \n\n \n36,737,790\n \n\n \n\n \n28,925,628\n \n\nAccumulated deficit\n\n \n\n \n(29,653,599)\n \n\n \n(29,600,786)\n\nTotal stockholders' deficit\n\n \n\n \n7,140,327\n \n\n \n\n \n(630,860)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nTotal liabilities and stockholders' deficit\n\n \n$7,824,000\n \n\n \n$-\n \n\n \n\n See accompanying notes to the financial statements\n\n \n\n \n\n4\n\n*Table of Contents*\n\n \n\n**LataMed AI Corp.**\n\n**(FKA Catalyst Crew Technologies Corp.)**\n\n**CONDENSED STATEMENTS OF OPERATIONS**\n\n**(Unaudited)**\n\n \n\n \n\n \n\n **For the three months ended **\n\n** **\n\n** **\n\n** **\n\n**March 31, 2026**\n\n** **\n\n** **\n\n**March 31, 2025**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nRevenue\n\n \n$-\n \n\n \n$-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOperating expenses\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nGeneral and administrative\n\n \n\n \n9,187\n \n\n \n\n \n967\n \n\nProfessional fees\n\n \n\n \n34,197\n \n\n \n\n \n15,000\n \n\nTotal operating expenses\n\n \n\n \n43,384\n \n\n \n\n \n15,967\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nLoss from operations\n\n \n\n \n(43,384)\n \n\n \n(15,967)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nOther income (expenses)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nInterest expense\n\n \n\n \n(9,429)\n \n\n \n(8,488)\n\nTotal other expenses\n\n \n\n \n(9,429)\n \n\n \n(8,488)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNet loss before tax provision\n\n \n\n \n(52,813)\n \n\n \n(24,455)\n\nTax provision\n\n \n\n \n-\n \n\n \n\n \n-\n \n\nNet loss\n\n \n$(52,813)\n \n$(24,455)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNet loss per common share - basic and diluted\n\n \n$(0.00)\n \n$(0.00)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nWeighted average number of common shares outstanding - basic and diluted\n\n \n\n \n56,134,795\n \n\n \n\n \n29,276,895\n \n\n \n\n  See accompanying notes to the financial statements\n\n \n\n \n\n5\n\n*Table of Contents*\n\n \n\n**LataMed AI Corp.**\n\n**(FKA Catalyst Crew Technologies Corp.)**\n\n** CONDENSED STATEMENTS OF STOCKHOLDERS' DEFICIT**\n\n**(Unaudited)**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n** Total **\n\n \n\n \n\n \n\n** Common Stock**\n\n \n\n \n\n** Additional**\n\n \n\n \n\n** Accumulated**\n\n \n\n \n\n**    Stockholders' **\n\n \n\n \n\n \n\n** Shares**\n\n \n\n \n\n** Amount**\n\n \n\n \n\n** Paid-in Capital**\n\n \n\n \n\n** Deficit**\n\n \n\n \n\n**   Deficit**\n\n \n\nBalance, December 31, 2025\n\n \n\n \n44,296,895\n \n\n \n\n \n44,298\n \n\n \n\n \n28,925,628\n \n\n \n\n \n(29,600,786)\n \n\n \n(630,860)\n\nShares issued for asset purchase agreement\n\n \n\n \n12,000,000\n \n\n \n\n \n12,000\n \n\n \n\n \n7,812,000\n \n\n \n\n \n-\n \n\n \n\n \n7,824,000\n \n\nShares returned and cancelled\n\n \n\n \n(162,100)\n \n\n \n(162)\n \n\n \n162\n \n\n \n\n \n-\n \n\n \n\n \n-\n \n\nNet loss\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n(52,813)\n \n\n \n(52,813)\n\nBalance, March 31, 2026\n\n \n\n \n56,134,795\n \n\n \n\n \n56,136\n \n\n \n\n \n36,737,790\n \n\n \n\n \n(29,653,599)\n \n\n \n7,140,327\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nBalance, December 31, 2024\n\n \n\n \n29,276,895\n \n\n \n\n \n29,278\n \n\n \n\n \n28,790,448\n \n\n \n\n \n(29,393,301)\n \n\n \n(573,575)\n\nNet loss\n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n-\n \n\n \n\n \n(24,455)\n \n\n \n(24,455)\n\nBalance, March 31, 2025\n\n \n\n \n29,276,895\n \n\n \n\n \n29,278\n \n\n \n\n \n28,790,448\n \n\n \n\n \n(29,417,756)\n \n\n \n(598,030)\n\n \n\n  See accompanying notes to the financial statements\n\n \n\n \n\n6\n\n*Table of Contents*\n\n \n\n**LataMed AI Corp.**\n\n**(FKA Catalyst Crew Technologies Corp.)**\n\n**  CONDENSED STATEMENTS OF CASH FLOWS**\n\n**(Unaudited)**\n\n \n\n \n\n \n\n** For the three months ended **\n\n** **\n\n** **\n\n** **\n\n**March 31, 2026**\n\n** **\n\n** **\n\n**March 31, 2025**\n\n \n\nCash Flows from Operating Activities\n\n \n\n \n\n \n\n \n\n \n\n \n\nNet loss\n\n \n$(52,813)\n \n$(24,455)\n\nAdjustments to reconcile net loss to net cash provided by operating activities:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nChanges in assets and liabilities\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nAccounts payable and accrued liabilities\n\n \n\n \n24,429\n \n\n \n\n \n5,440\n \n\nNet cash used in continuing operating activities\n\n \n\n \n(28,384)\n \n\n \n(19,015)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCash Flows from Financing Activities:\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nProceeds from notes payable\n\n \n\n \n28,384\n \n\n \n\n \n19,015\n \n\nNet cash provided by financing activities\n\n \n\n \n28,384\n \n\n \n\n \n19,015\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nNet decrease in cash\n\n \n\n \n-\n \n\n \n\n \n-\n \n\nCash, beginning of period\n\n \n\n \n-\n \n\n \n\n \n-\n \n\nCash, end of period\n\n \n$-\n \n\n \n$-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nSupplemental disclosure of cash flow information\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nCash paid for interest\n\n \n$-\n \n\n \n$-\n \n\nCash paid for taxes\n\n \n$-\n \n\n \n$-\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n**SUPPLEMENTARY DISCLOSURE OF NON-CASH INVESTING AND FINANCING ACTIVITIES:**\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\nShares issued for intangible assets\n\n \n$-\n \n\n \n$875,000\n \n\n \n\n  See accompanying notes to the financial statements\n\n \n\n \n\n7\n\n*Table of Contents*\n\n \n\n**LataMed AI Corp.**\n\n**(FKA Catalyst Crew Technologies Corp.)**\n\n**NOTES TO FINANCIAL STATEMENTS**\n\n**MARCH 31, 2026**\n\n \n\n**NOTE 1 – NATURE OF BUSINESS AND OPERATIONS**\n\n \n\n**Organization**\n\n \n\nLataMed AI Corp.(FKA Catalyst Crew Technologies Corp.) (the “Company or “CBBB”) was incorporated in the State of Nevada on September 11, 2008. At that time the primary business of the Company was to act as a global broker for business and private jets by connecting travelers (corporations, institutions and wealthy private individuals) with executive aircraft that are independently owned and operated by third party companies or individuals. On February 5, 2015, the Company changed its name to better reflect its anticipated new business direction. The Company had received approval of its Federal Permit to distribute alcoholic beverages, which would be accomplished, through its subsidiaries, Continental Beverage Inventory and Warehousing Ltd., and promotional activities through Continental Beverage Marketing and Promotion Inc. In early 2016, the Company abandoned its activities and ceased to operate.\n\n \n\nOn March 20, 2023, the “Company entered into an Asset Purchase Agreement by and among the Company, on the one hand and JT Technologies LLC (“JTLLC”) and Nitish Sharma, an individual and the sole managing member of JTLLC, on the other hand whereby the Company acquired various big data analytics related assets from the Seller for use in the gaming and gambling industry to analyze player behavior and fraud protection, among other similar information. Collectively, al intellectual property, proprietary and non-proprietary technology, know-how, and all other assets of the seller that maybe, directly, or indirectly, applied to big data analytics in the gaming and gaming industry are referred to hereinafter as the “Acquired Assets”. In exchange for the Acquired Assets, the Company issued 5,000,000 restricted shares of the 2. Buyer’s common stock to Seller.\n\n \n\nOn May 26, 2023, the Company changed its name to Blue Chip Technologies Corporation.\n\n \n\nOn September 18, 2023, the Company received notice of resignation from Mr. Andrew Gaudet from the positions of President, Chief Executive Officer, Treasurer, Chief Financial Officer, and Secretary. Mr. Gaudet retained his position as a member of the Company’s Board of Directors.\n\n \n\nEffective the same day, the Company entered into an Executive Employment with Gurneet Kaur whereby Ms. Kaur agreed to serve as the Company’s Chief Executive Officer, President, Chief Financial Officer, Treasurer, Secretary, and as Chairman of the Company’s Board of Directors. On the same day, and pursuant to a Stock Purchase Agreement, Ms. Kaur acquired 48,944,965 shares of common stock from Nitish Sharma. Accordingly, Ms. Kaur now owns 72,944,965 restricted shares of our common stock, which represents approximately 66.53% of the total issued and outstanding shares of common stock.\n\n \n\nOn June 5, 2024, Ms. Kaur sold, by way of Stock Purchase Agreement (the “SPA”), 72,944,965 restricted shares of the Company’s common stock to Waqas Nakhwa. As a result of this SPA, Nakhwa is now deemed our controlling shareholder by virtue of his purchase of the Shares and holds 66.53% of our total voting stock.\n\n \n\nAdditionally, on June 7, 2024, the Company received notice of resignation from Ms. Kaur from the positions of President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Director of the Company. Ms. Kaur’s resignation was not the result of any disagreements between Ms. Kaur and the Company relating to the Company’s operations, policies, or practices.\n\n \n\nEffective immediately upon the resignation of Ms. Kaur, the Company’s Board of Directors appointed Mr. Nakhwa to serve as President, Chief Executive Officer, Treasurer, Chief Financial Officer, Secretary and Chairman of the Board of Directors to serve until the next annual meeting of the Company or until his respective successor is duly appointed. Mr. Nakhwa accepted all such appointments, effective as of June 7, 2024.\n\n \n\n \n\n8\n\n*Table of Contents*\n\n \n\n \n\nOn June 9, 2024, the Company entered into an Asset  Transfer Agreement with Mr. Nakhwa pursuant to which Mr. Nakhwa assigned to the Company all of Mr. Nakhwa’s interest in Facial Recognition Technology (FRT) solutions and intellectual property associated therewith in exchange for $1.00.\n\n \n\nOn June 11, 2024, as a result of this change in management, the Company’s Board of Directors voted to (i) cease all prior operations of the Company involving big data analytics software for use in the gaming and financial technology industries, (ii) relinquish and disavow any and all interest in existing subsidiaries as of June 11, 2024 and (iii) amend the Company’s Articles of Incorporation to change the name of the Company to **“Catalyst Crew Technologies Corp.”** to more accurately reflect the Company’s new business direction.  The Company will endeavor to affect the name change in near future or at such time management deems the name change appropriate. In the interim period until we affect this proposed name change, we will be operating as “**Catalyst Crew Technologies.**\n\n \n\nOn July 1, 2024, the Company’s Board of Directors approved a Change to its Articles of Incorporation, as amended, with the Secretary of Nevada to change the Company’s corporate name to “Catalyst Crew Technologies Corp.”\n\n \n\nOn February 17, 2026, the Company appointed Kevin Rodan Levy to serve as Chief Executive Officer, President, Chief Financial Officer, Secretary, Treasurer, and sole board member of the Company, effective immediately. On April 28, 2026, the Company filed a Certificate of Amendment with the Nevada Secretary of State changing the Company’s corporate name to \"LataMed AI Corp.,\" which became effective upon filing.\n\n \n\nOn March 31, 2026, the Company's Board of Directors appointed Carlos Peña as Chief Financial Officer of the Company, effective immediately. Mr. Peña replaced Kevin Rodan Levy in the CFO role. Mr. Rodan Levy continues to serve as Chief Executive Officer, President, Secretary, Treasurer, and sole Director of the Company.\n\n \n\n**BASIS OF PRESENTATION**\n\n** **\n\nThe accompanying financial statements have been prepared on the accrual basis of accounting in accordance with accounting principles generally accepted in the United States. Management is of the opinion that all necessary adjustments have been made to make these interim financial statements not misleading.\n\n  \n\n**NOTE 2 – GOING CONCERN**\n\n \n\nThe accompanying financial statements have been prepared in US dollars and in accordance with accounting principles generally accepted in the United States (“GAAP”) on a going concern basis, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. During three months ended March 31, 2026, the Company incurred net losses of $52,813 and accumulated deficits of $29,653,599. These conditions raise substantial doubt about the Company's ability to continue as a going concern.\n\n \n\nWe are entirely dependent on our ability to attract and receive funding from either the sale of securities or outside sources such as private investment or a strategic partner. We currently have no firm agreements or arrangements with respect to any such financing and there can be no assurance that any needed funds will be available to us on acceptable terms or at all. The inability to obtain sufficient funding of our operations in the future will restrict our ability to grow and reduce our ability to continue to conduct business operations. Our failure to raise additional funds will adversely affect our business, and may require us to suspend our operations, which in turn may result in a loss to the purchasers of our common stock. If we are unable to obtain necessary financing, we will likely be required to curtail our development plans. Any additional equity financing may involve substantial dilution to our then existing stockholders.\n\n \n\n**NOTE 3 – SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES**\n\n \n\n**Use of Estimates**\n\nThe preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.\n\n \n\n \n\n9\n\n*Table of Contents*\n\n \n\n \n\n**Cash and Cash Equivalents**\n\nFor purposes of the statement of cash flows, the Company considers all highly liquid debt instruments purchased with a maturity of three months or less to be cash equivalents to the extent the funds are not being held for investment purposes.\n\n \n\n**Stock-based compensation**\n\nThe Company follows ASC 718-10, “Stock Compensation”, which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, “Accounting for Stock-Based Compensation,” and supersedes Accounting Principles Board (“APB”) Opinion No. 25, “Accounting for Stock Issued to Employees,” and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized.\n\n \n\n**Concentration of Credit Risk**\n\nThe Company has no off-balance-sheet concentrations of credit risk such as foreign exchange contracts, options contracts or other foreign hedging arrangements. The Company maintains all of its cash balances with two financial institutions in the form of demand deposits.\n\n \n\n**Earnings per share**\n\nThe Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share (“EPS”) calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.\n\n \n\n**Revenue Recognition**\n\nThe Company recognizes revenue from its contracts with customers in accordance with *ASC 606 – Revenue from Contracts with Customers.*The Company recognizes revenues when satisfying the performance obligation of the associated contract that reflects the consideration expected to be received based on the terms of the contract.\n\n \n\nRevenue related to contracts with customers is evaluated utilizing the following steps: (i) Identify the contract, or contracts, with a customer; (ii) Identify the performance obligations in the contract; (iii) Determine the transaction price; (iv) Allocate the transaction price to the performance obligations in the contract; (v) Recognize revenue when the Company satisfies a performance obligation.\n\n \n\n**Fair Value of Financial Instruments**\n\nThe Company measures fair value in accordance with ASC 820 - Fair Value Measurements. ASC 820 defines fair value and establishes a three-level valuation hierarchy for disclosures of fair value measurements. ASC 820 establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. To increase consistency and comparability in fair value measurements and related disclosures, ASC 820 establishes a fair value hierarchy which prioritizes the inputs to valuation techniques used to measure fair value into three (3) broad levels. The fair value hierarchy gives the highest priority to quoted prices (unadjusted) in active markets for identical assets or liabilities and the lowest priority to unobservable inputs. The three (3) levels of fair value hierarchy defined by ASC 820 are:\n\n \n\nLevel 1 - Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date.\n\n \n\nLevel 2 - Inputs (other than quoted market prices included in Level 1) are either directly or indirectly observable for the asset or liability through correlation with market data at the measurement date and for the duration of the instrument’s anticipated life.\n\n \n\nLevel 3 - Inputs reflect management’s best estimate of what market participants would use in pricing the asset or liability at the measurement date. Consideration is given to the risk inherent in the valuation technique and the risk inherent in the inputs to the model. Valuation of instruments includes unobservable inputs to the valuation methodology that are significant to the measurement of fair value of assets or liabilities.\n\n \n\n \n\n \n\n10\n\n*Table of Contents*\n\n \n\nAs defined by ASC 820, the fair value of a financial instrument is the amount at which the instrument could be exchanged in a current transaction between willing parties, other than in a forced or liquidation sale, which was further clarified as the price that would be received to sell an asset or paid to transfer a liability (“an exit price”) in an orderly transaction between market participants at the measurement date\n\n \n\nThe reported fair values for financial instruments that use Level 2 and Level 3 inputs to determine fair value are based on a variety of factors and assumptions. Accordingly, certain fair values may not represent actual values of the Company’s financial instruments that could have been realized as of March 31, 2025 and December 31, 2024 or that will be recognized in the future, and do not include expenses that could be incurred in an actual settlement. The carrying amounts of the Company’s financial assets and liabilities, such as cash, accounts receivable, receivables from related parties, prepaid expenses and other, accounts payable, accrued liabilities, and related party and third-party notes payables approximate fair value due to their relatively short maturities. The Company’s notes payable approximates the fair value of such instrument based upon management’s best estimate of terms that would be available to the Company for similar financial arrangements on March 31, 2025 and December 31, 2024.\n\n \n\n**Recent Accounting Pronouncements**\n\n \n\nIn November 2023, the FASB issued ASU 2023-07, Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures. The amendments in this ASU require disclosures, on an annual and interim basis, of significant segment expenses that are regularly provided to the chief operating decision maker (“CODM”), as well as the aggregate amount of other segment items included in the reported measure of segment profit or loss. This ASU requires that a public entity disclose the title and position of the CODM and an explanation of how the CODM uses the reported measure(s) of segment profit or loss in assessing segment performance and deciding how to allocate resources. This ASU is effective for fiscal years beginning after December 15, 2023, including interim periods within those fiscal years, with early adoption permitted. The amendments in this ASU should be applied retrospectively to all prior periods presented in the financial statements. The Company adopted the ASU and determined that its adoption did not have a material impact on the Company’s financial statements and related disclosures. As defined in the ASU, operating segments are components of an enterprise about which discrete financial information is regularly provided to the CODM in making decisions on how to allocate resources and assess performance for the organization. The Company operates and manages its business as one reportable and operating segment. The Company’s CODM is the Chief Executive Officer. The Company’s CODM reviews operating results to make decisions about allocating resources and assessing performance for the entire Company.\n\n  \n\nThe Company does not believe that other standards, which have been issued but are not yet effective, will have a significant impact on its financial statements.\n\n \n\n**NOTE 4 – ASSET PURCHASE AGREEMENTS**\n\n \n\nOn February 17, 2026, the Company entered into an Asset Purchase Agreement pursuant to which the Company acquired various proprietary assets and intellectual property for 12,000,000 restricted shares of common stock valued at $7,932,000.\n\n \n\nThe Company evaluated the Asset Purchase Agreement in accordance with ASC 805 – Business Combinations which notes the threshold requirements of a business combination that includes the expanded definition of a “business” and defines elements that are to be present to be determined whether an acquisition of a business occurred. No “activities” of the acquiree were acquired. Instead, the Company obtained control of a set of inputs (the acquired assets). Thus, the Company determined agreement is an acquisition of assets, not an acquisition of a business in accordance with ASC 805. Management evaluated the assets and determined the value to $7,932,000 as of March 31, 2026.\n\n \n\n \n\n11\n\n*Table of Contents*\n\n \n\n**NOTE 5 – NOTES PAYABLE**\n\n \n\nPromissory notes payable as of March 31, 2026 and December 31, 2025 consists of the following:\n\n \n\n**March 31, 2026**\n\n \n\n \n\n**December 31, 2025**\n\n \n\n$\n73,228\n\n \n\n \n$73,228\n \n\n \n\n2,500\n\n \n\n \n\n \n2,500\n \n\n \n\n20,000\n\n \n\n \n\n \n20,000\n \n\n \n\n4,571\n\n \n\n \n\n \n4,571\n \n\n \n\n763\n\n \n\n \n\n \n763\n \n\n \n\n7,341\n\n \n\n \n\n \n7,341\n \n\n \n\n2,500\n\n \n\n \n\n \n2,500\n \n\n \n\n5,000\n\n \n\n \n\n \n5,000\n \n\n \n\n13,000\n\n \n\n \n\n \n13,000\n \n\n \n\n8,000\n\n \n\n \n\n \n8,000\n \n\n \n\n976\n\n \n\n \n\n \n976\n \n\n \n\n12,000\n\n \n\n \n\n \n12,000\n \n\n \n\n3,500\n\n \n\n \n\n \n3,500\n \n\n \n\n5,000\n\n \n\n \n\n \n5,000\n \n\n \n\n6,123\n\n \n\n \n\n \n6,123\n \n\n \n\n5,000\n\n \n\n \n\n \n5,000\n \n\n \n\n12,000\n\n \n\n \n\n \n12,000\n \n\n \n\n1,341\n\n \n\n \n\n \n1,341\n \n\n \n\n1,498\n\n \n\n \n\n \n1,498\n \n\n \n\n5,300\n\n \n\n \n\n \n5,300\n \n\n \n\n3,000\n\n \n\n \n\n \n3,000\n \n\n \n\n1,791\n\n \n\n \n\n \n1,791\n \n\n \n\n7,500\n\n \n\n \n\n \n7,500\n \n\n \n\n4,500\n\n \n\n \n\n \n4,500\n \n\n \n\n668\n\n \n\n \n\n \n668\n \n\n \n\n6,500\n\n \n\n \n\n \n6,500\n \n\n \n\n3,113\n\n \n\n \n\n \n3,113\n \n\n \n\n250\n\n \n\n \n\n \n250\n \n\n \n\n6,500\n\n \n\n \n\n \n6,500\n \n\n \n\n10,000\n\n \n\n \n\n \n10,000\n \n\n \n\n2,265\n\n \n\n \n\n \n2,265\n \n\n \n\n980\n\n \n\n \n\n \n980\n \n\n \n\n10,000\n\n \n\n \n\n \n10,000\n \n\n \n\n3,874\n\n \n\n \n\n \n3,874\n \n\n \n\n3,500\n\n \n\n \n\n \n3,500\n \n\n \n\n5,000\n\n \n\n \n\n \n5,000\n \n\n \n\n3,500\n\n \n\n \n\n \n3,500\n \n\n \n\n1,832\n\n \n\n \n\n \n1,832\n \n\n \n\n742\n\n \n\n \n\n \n742\n \n\n \n\n7,148\n\n \n\n \n\n \n7,148\n \n\n \n\n374\n\n \n\n \n\n \n-\n \n\n \n\n28,010\n\n \n\n \n\n \n-\n \n\n$\n300,688\n\n \n\n \n$272,304\n \n\n \n\nDuring the three months ended March 31, 2026, the Company has issued various promissory notes amounting to $28,384 for general operating purposes. The notes carry an interest rate of 10% and are due upon demand.\n\n  \n\nDuring the three months ended March 31, 2026 and 2025, the Company recorded interest expense related to these notes of $5,488 and $4,547, respectively.\n\n \n\n \n\n12\n\n*Table of Contents*\n\n \n\n**NOTE 6 – CONVERTIBLE NOTES PAYABLE**\n\n \n\nConvertible notes payable as of March 31, 2026 and December 31, 2025 consists of the following:\n\n \n\n**March 31, 2026**\n\n \n\n \n\n**December 31, 2025**\n\n \n\n$\n15,487\n\n \n\n \n$15,487\n \n\n \n\n11,103\n\n \n\n \n\n \n11,103\n \n\n \n\n8,000\n\n \n\n \n\n \n8,000\n \n\n$\n34,591\n\n \n\n \n$34,591\n \n\n \n\nDuring the three months ended March 31, 2026 and 2025, the Company recorded interest expense of $1,771 and  $1,771, respectively.\n\n \n\n**NOTE 7 – RELATED PARTY TRANSACTIONS**\n\n \n\nAs of March 31, 2026 and December 31, 2025, the Company had notes due to its majority shareholder, Kevin Rodan Levy, of $88,042 and $88,042, respectively. The notes carry an interest rate of 10% and are due upon demand.\n\n \n\nDuring the three months ended March 31, 2026 and 2025, the Company recorded interest expense related to these notes of $2,171 and $2,171, respectively.\n\n \n\n**NOTE 8 – COMMITMENTS AND CONTINGENCIES**\n\n \n\nFrom time to time, the Company may become involved in various lawsuits and legal proceedings, which arise in the ordinary course of business. Litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm business. Management is currently not aware of any such legal proceedings or claims that could have, individually or in the aggregate, a material adverse effect on our business, financial condition, or operating results.\n\n \n\n**NOTE 9 – STOCKHOLDERS’ EQUITY**\n\n \n\nAs of  March 31, 2026 and December 31, 2025, the Company had 56,134,795 and 44,296,895 shares of common stock issued and outstanding.\n\n \n\nOn July 1, 2024, the Company’s Board of Directors approved a One for Four Hundred Fifty (1-for-450) Reverse Stock Split of the issued and outstanding shares of Common Stock. The financial statements have been retroactively restated to reflect the split.\n\n \n\nOn October 12, 2023, the Board of Directors authorize an amendment to the articles of Incorporation to specifically increase the authorized shares to One Billion (1,000,000,000), consisting of; (i) Seven Hundred Million (700,000,000) shares of Common Stock, par value $0.0001 per share, Three Hundred Million (300,000,000) shares of preferred stock, par value $0.0001 per share which are issuable in one or more Series; to designate 10,000,000 preferred shares as Series A Preferred Stock and, (iv) to designate 10,000,000 preferred shares as Series B Preferred Stock.\n\n \n\n \n\n13\n\n*Table of Contents*\n\n \n\n \n\nThe Series A Preferred Stock shall rank senior to all Common Stock and any other class of securities that is specifically designated as junior to the Series A Preferred Stock however, does not have the right to vote. The Series A Preferred Stock is entitled to receive dividends from the Issuance Date thereof at the annual rate of three percent (3%) of the Original Issue Price, payable by the Board of Directors in quarterly installments. The Dividends shall cease to accrue on shares of Series A Preferred Stock on the date of any Conversion, as set forth herein. Each share of Series A Preferred Stock shall be convertible at the option of the holder after the One (1) Year anniversary of the Issuance Date, into a number of shares of Common Stock determined by dividing (i) the total number of Series A Preferred Shares being converted by (ii) the Conversion Price (the “Conversion Ratio”). The conversion price for the Series A Preferred Stock (the “Conversion Price”) shall be equal to $1.00 per share, which may be adjusted from time to time as hereinafter provided.\n\n  \n\nSeries B Preferred Stock shall rank senior to all Common Stock and pari passu to the Series A Preferred Stock. Each share of Series B Preferred Stock shall be convertible at the option of the Holder thereof at any time, and from time to time, from and after the One (1) Year anniversary of the Issuance Date, into a number of shares of Common Stock determined by dividing (i) the total number of Series B Preferred Shares being converted by (ii) the Conversion Price The conversion price for the Series B Preferred Stock (the “Conversion Price”) shall be equal to $1.00 per share, which may be adjusted from time to time.  Series B Preferred Stock shall not have the right to vote on any matters, questions, or proceedings of this Corporation. Holders of the Series B Preferred Stock must hold their Preferred shares for a period one (1) year from the Issuance Date prior to converting their Series B Preferred Shares to Common Shares.\n\n \n\nFollowing the expiration of the Hold Period, the Corporation shall issue to the Holders bonus shares of the Corporation’s Common Stock in such amount to be the number of Series B Preferred held by each Holder by (ii)”). The Board of Directors shall have the authority, in its discretion, to grant the Bonus Shares to the Holders. Each Bonus Share shall constitute a transfer of a restricted Common Share to the Holder, without other payment therefor, as a bonus to the Holder.\n\n \n\nOn February 17, 2026, a shareholder returned and the Company cancelled 162,100 shares of common stock for no consideration.\n\n \n\nOn March 10, 2026, the Company issued 12,000,000 shares of common stock valued at $7,932,000 for certain intangible assets.\n\n \n\n**NOTE 10 – SUBSEQUENT EVENTS**\n\n \n\nIn accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to March 31, 2026 through the date these financial statements were available to be issued and has identified the following material subsequent events:\n\n \n\nOn April 28, 2026, the Company filed a Certificate of Amendment to its Articles of Incorporation with the Nevada Secretary of State, changing the Company's corporate name from \"Catalyst Crew Technologies Corp.\" to \"LataMed AI Corp.\" The name change became effective upon filing.\n\n \n\nOn May 6, 2026, the Board of Directors of the Company approved the designation of a new series of preferred stock designated as the \"Series C Voting Preferred Stock\" and filed a Certificate of Designation with the Nevada Secretary of State. The principal terms include: (i) 5,000,000 authorized shares; (ii) voting rights of twenty (20) votes per share, voting together with the Company's common stock as a single class on all matters submitted to stockholders; (iii) non-convertible; (iv) liquidation preference senior to Common Stock and pari passu with any other series of Preferred Stock; and (v) non-redeemable. Protective provisions require approval of holders of a majority of outstanding Series C Preferred Stock prior to, among other things, creating or issuing any class of capital stock ranking senior to the Series C Preferred Stock, amending the terms of the Series C Preferred Stock in a manner adverse to its holders, or liquidating, dissolving, or winding up the Company.\n\n \n\nOther than the foregoing, the Company has determined that it does not have any other material subsequent events to disclose in these financial statements.\n\n \n\n \n\n14\n\n*Table of Contents*"}